E3 ubiquitin ligases and human papillomavirus-induced carcinogenesis
Open accessAbstract
Human papillomavirus (HPV) infection is clinically very common. It is usually a major risk factor in the development of cutaneous benign lesions, cervical cancer and a variety of other malignancies. The biological function of ubiquitination as an intracellular proteasomal-mediated form of protein degradation and an important modulator in the regulation of many fundamental cellular processes has been increasingly recognized over the last decade. HPV proteins have been demonstrated to evolve different strategies to utilize the ubiquitin system for their own purposes. The putative roles of E3 ubiquitin ligases in HPV-induced carcinogenesis have become increasingly apparent, although the mechanisms remain unclear. In this review we provide an update on the mechanisms of the involvement of E3 ubiquitin ligases in HPV-induced carcinogenesis, focusing on their interaction with HPV proteins and their roles in several signalling pathways. Targeting the E3 ubiquitin ligases might offer potential therapeutic strategies for HPV-related diseases in future.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The E6 protein of human papillomavirus type 16 (HPV-16) and type 18 (HPV-18) recruits the human E3 ligase, ubiquitin-protein ligase E3A (UBE3A; also known as E6AP) to ubiquitylate p53, resulting in its degradation.
“For example, the E6 protein of human papillomavirus type 16 (HPV-16) and type 18 (HPV-18) recruits the human E3 ligase, ubiquitin–protein ligase E3A (UBE3A; also known as E6AP) to ubiquitylate p53, resulting in its degradation236.”
From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [236]
Cites
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · see citing works
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Glickman, M. H., & Ciechanover, A. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00027.2001 · Cited by 4,216 · see citing works
Classification of papillomaviruses
de Villiers, E., Fauquet, C., Broker, T. R., Bernard, H., & Hausen, H. Z. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,192 · see citing works
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,387 · see citing works
The ubiquitin-proteasome proteolytic pathway
Ciechanover, A. J. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,804 · see citing works
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801 · see citing works
Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T., Shalet, S. M., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16044-3 · Cited by 1,697 · see citing works
Chaturvedi, A. K., Engels, E. A., Anderson, W. F., & Gillison, M. L. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1713 · Cited by 1,568 · see citing works
Gillison, M. L., DʼSouza, G., Westra, W. H., Sugar, E. A., Xiao, W., Begum, S., & Viscidi, R. P. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn025 · Cited by 1,548 · see citing works
Connections with Connexins: the Molecular Basis of Direct Intercellular Signaling
Bruzzone, R., White, T. W., & Paul, D. L. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0001q.x · Cited by 1,311 · see citing works
Münger, K., Werness, B. A., Dyson, N. J., Phelps, W. C., Harlow, E. E., & Howley, P. M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08594.x · Cited by 1,204 · see citing works
Ubiquitin signalling in the NF-κB pathway
Chen, Z. J. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-758 · Cited by 1,184 · see citing works
New insights into TGF-β–Smad signalling
ten Dijke, P., & Hill, C. S. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.03.008 · Cited by 1,176 · see citing works
Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044 · see citing works
The Tyrosine Kinase Negative Regulator c-Cbl as a RING-Type, E2-Dependent Ubiquitin-Protein Ligase
Joazeiro, C. A. P., Wing, S. S., Huang, H.-K., Leverson, J. D., Hunter, T. R., & Liu, Y. (1999) · Science · doi:10.1126/science.286.5438.309 · Cited by 1,036 · see citing works
Gap junctions and the connexin protein family
Söhl, G. (2003) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.013 · Cited by 986 · see citing works
Rubinstein, L., Shoemaker, R. H., Paull, K. D., Simon, R. M., Tosini, S., Skehan, P., Scudiero, D. A., Monks, A. P., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1113 · Cited by 927 · see citing works
Boyer, S. N., Wazer, D. E., & Band, V. (1996) · PubMed · Cited by 909 · see citing works
Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W. (2003) · Science · doi:10.1126/science.1091362 · Cited by 804 · cited 1× · see citing works
“The effects of Mdm2 on p53 are concentration-dependent: low Mdm2 induces p53 monoubiquitination and nuclear export; high Mdm2 promotes polyubiquitination and nuclear degradation.(79) Interestingly, research showed that Mdm2 enhances transcriptional activity of HPV E2 protein, which is critical for the regulation of th…”
BackgroundSmall molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumors
Issaeva, N., Bozko, P. M., Enge, M., Protopopova, M., Verhoef, L. G. G. C., Masucci, M. G., Pramanik, A., & Selivanova, G. (2004) · Nature Medicine · doi:10.1038/nm1146 · Cited by 749 · see citing works
Rajah, R., Valentinis, B., & Cohen, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12181 · Cited by 730 · see citing works
Drug discovery in the ubiquitin–proteasome system
Nalepa, G., Rolfe, M., & Harper, J. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2056 · Cited by 619 · see citing works
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.775 · Cited by 553 · see citing works
The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture
Ingham, R. J., Gish, G. D., & Pawson, T. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207436 · Cited by 531 · see citing works
Dayyani, F., Etzel, C. J., Liu, M., Ho, C., Lippman, S. M., & Tsao, A. S. (2010) · Head & Neck Oncology · doi:10.1186/1758-3284-2-15 · Cited by 528 · see citing works
Nakagawa, S., & Huibregtse, J. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.8244-8253.2000 · Cited by 466 · see citing works
Nees, M., Geoghegan, J. M., Hyman, T., Frank, S., Miller, L. D., & Woodworth, C. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4283-4296.2001 · Cited by 387 · see citing works
Dyson, N. J., Guida, P. M., Münger, K., & Harlow, E. E. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.6893-6902.1992 · Cited by 385 · see citing works
Huh, K.-W., Zhou, X., Hayakawa, H., Cho, J., Libermann, T. A., Jin, J., Harper, J. W., & Münger, K. (2007) · Journal of Virology · doi:10.1128/jvi.00881-07 · Cited by 286 · see citing works
Conformational Flexibility Underlies Ubiquitin Ligation Mediated by the WWP1 HECT Domain E3 Ligase
Verdecia, M. A., Joazeiro, C. A. P., Wells, N. J., Ferrer, J.-L., Bowman, M. E., Hunter, T. R., & Noel, J. P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00774-8 · Cited by 282 · see citing works
Jones, D. L., Thompson, D. A., & Münger, K. (1997) · Virology · doi:10.1006/viro.1997.8851 · Cited by 262 · see citing works
Tedesco, D., Lukas, J., & Reed, S. I. (2002) · Genes & Development · doi:10.1101/gad.1011202 · Cited by 261 · see citing works
MDM2 Is a Negative Regulator of p21 , Independent of p53
Zhang, Z., Wang, H., Li, M., Agrawal, S., Chen, X., & Zhang, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312264200 · Cited by 253 · see citing works
Regulation of TGF‐β family signaling by E3 ubiquitin ligases
Inoue, Y., & Imamura, T. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00925.x · Cited by 246 · see citing works
Clinician's guide to human papillomavirus immunology: knowns and unknowns
Einstein, M. H., Schiller, J. T., Viscidi, R. P., Strickler, H. D., Coursaget, P., Tan, T. Q., Halsey, N. A., & Jenkins, D. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70108-2 · Cited by 226 · see citing works
Gross-Mesilaty, S., Reinstein, E., Bercovich, B., Tobias, K. E., Schwartz, A. L., Kahana, C., & Ciechanover, A. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8058 · Cited by 215 · see citing works
Thomas, M., & Banks, L. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-6-1513 · Cited by 211 · see citing works
Leechanachai, P., Banks, L., Moreau, F., & Matlashewski, G. (1992) · PubMed · Cited by 210 · see citing works
Wing, S. S. (2003) · International Journal of Biochemistry and Cell Biology · doi:10.1016/s1357-2725(02)00392-8 · Cited by 204 · see citing works
SCF-mediated protein degradation and cell cycle control
Cambronne, X. A., & Harper, J. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208614 · Cited by 193 · see citing works
The role of human papillomavirus infection in head and neck cancers
Syrjänen, S. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq454 · Cited by 185 · see citing works
Kühne, C., & Banks, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34302 · Cited by 182 · see citing works
Zhang, B., Chen, W., & Roman, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510012103 · Cited by 178 · see citing works
Characterization of Human hect Domain Family Members and Their Interaction with UbcH5 and UbcH7
Schwarz, S. E., Rosa, J. L., & Scheffner, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12148 · Cited by 174 · see citing works
Reinstein, E., Scheffner, M., Oren, M., Ciechanover, A. J., & Schwartz, A. L. (2000) · Oncogene · doi:10.1038/sj.onc.1203989 · Cited by 174 · see citing works
Human papillomavirus-induced carcinogenesis and the ubiquitin–proteasome system
Scheffner, M., & Whitaker, N. J. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00100-1 · Cited by 164 · see citing works
Extended follow‐up of a phase II trial in relapsed, refractory multiple myeloma:
Richardson, P. G. G., Barlogie, B., Berenson, J. R., Singhal, S., Jagannath, S., Irwin, D. H., Rajkumar, S. V., Srkalović, G., Alsina, M., & Anderson, K. C. (2006) · Cancer · doi:10.1002/cncr.21740 · Cited by 150 · see citing works
Bouvard, V., Matlashewski, G., Gu, Z., Storey, A., & Banks, L. (1994) · Virology · doi:10.1006/viro.1994.1456 · Cited by 147 · see citing works
The loss of mdm2 induces p53 mediated apoptosis
de Rozìeres, S., Maya, R. B.-Y., Oren, M., & Lozano, G. (2000) · Oncogene · doi:10.1038/sj.onc.1203468 · Cited by 144 · see citing works
Ubiquitin protein ligase Nedd4 binds to connexin43 by a phosphorylation-modulated process
Leykauf, K., Salek, M., Bomke, J., Frech, M., Lehmann, W., Dürst, M., & Alonso, Á. (2006) · Journal of Cell Science · doi:10.1242/jcs.03149 · Cited by 138 · see citing works
Mishra, A., Bharti, A. C., Varghese, P., Saluja, D., & Das, B. C. (2006) · International Journal of Cancer · doi:10.1002/ijc.22262 · Cited by 136 · see citing works
The E5 Gene of HPV-16 Enhances Keratinocyte Immortalization by Full-Length DNA
Stoppler, M. C., Straight, S. W., Tsao, G., Schlegel, R., & McCance, D. J. (1996) · Virology · doi:10.1006/viro.1996.0475 · Cited by 121 · see citing works
Callaghan, M. J., Russell, A. J., Woollatt, E., Sutherland, G. R., Sutherland, R. L., & Watts, C. K. W. (1998) · Oncogene · doi:10.1038/sj.onc.1202249 · Cited by 117 · see citing works
King, T. J., Fukushima, L. H., Hieber, A., Shimabukuro, K., Sakr, W., & Bertram, J. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.6.1097 · Cited by 106 · see citing works
Ming, J., Bohl, J., Brimer, N., Kinter, M. T., & Pol, S. V. (2006) · Journal of Virology · doi:10.1128/jvi.01979-06 · Cited by 105 · see citing works
Zhang, B., Srirangam, A., Potter, D. A., & Roman, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208453 · Cited by 98 · see citing works
Clancy, J. L., Henderson, M. J., Russell, A. J., Anderson, D. W., Bova, R., Campbell, I., Choong, D. Y., Macdonald, G. A., Mann, G. J., Nolan, T., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206775 · Cited by 96 · see citing works
Lee, D. K., Kim, B.-C., Kim, I. Y., Cho, E.-A., Satterwhite, D. J., & Kim, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206786200 · Cited by 96 · see citing works
Mannhardt, B., WEINZIMER, S. A., Wagner, M., Fiedler, M., Cohen, P., Jansen‐Dürr, P., & Zwerschke, W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.17.6483-6495.2000 · Cited by 94 · see citing works
Roh, J., Kang, S. K., Minn, I., Califano, J. A., Sidransky, D., & Koch, W. M. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2010.10.011 · Cited by 93 · see citing works
Srivenugopal, K. S., & Ali‐Osman, F. (2002) · Oncogene · doi:10.1038/sj.onc.1205762 · Cited by 87 · see citing works
Yuan, H., Fu, F., Zhuo, J., Wang, W., Nishitani, J., An, D. S., Chen, I. S. Y., & Liu, X. (2005) · Oncogene · doi:10.1038/sj.onc.1208691 · Cited by 86 · see citing works
Oh, K.-J., Kalinina, A., Wang, J., Nakayama, K., Nakayama, K., & Bagchi, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5338-5346.2004 · Cited by 83 · see citing works
Shen, M., Hsu, Y.-M., Hsu, K., Chen, Y., Tang, M., & Chou, C.-Y. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi336 · Cited by 82 · see citing works
Bellanger, S., Blachon, S., Méchali, F., Bonne-Andréa, C., & Thierry, F. (2005) · Cell Cycle · doi:10.4161/cc.4.11.2123 · Cited by 78 · see citing works
SOC1 inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein
Kamio, M., Yoshida, T., Ogata, H., Douchi, T., Nagata, Y., Inoue, M., Hasegawa, M., Yonemitsu, Y., & Yoshimura, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207453 · Cited by 73 · see citing works
Favre-Bonvin, A., Reynaud, C., Kretz‐Remy, C., & Jalinot, P. (2005) · Journal of Virology · doi:10.1128/jvi.79.7.4229-4237.2005 · Cited by 72 · see citing works
NFX1 Interacts with mSin3A/Histone Deacetylase To Repress hTERT Transcription in Keratinocytes
Xu, M., Luo, W., Elzi, D. J., Grandori, C., & Galloway, D. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01969-07 · Cited by 70 · see citing works
Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase.
Gao, Q., Kumar, A., Singh, L., Huibregtse, J. M., Beaudenon, S. L., Srinivasan, S. V., Wazer, D. E., Band, H., & Band, V. (2002) · PubMed · Cited by 69 · see citing works
Tomaić, V., Pim, D., Thomas, M., Massimi, P., Myers, M. P., & Banks, L. (2011) · Journal of Virology · doi:10.1128/jvi.02004-10 · Cited by 66 · see citing works
Johnson, E. S. (2002) · Nature Cell Biology · doi:10.1038/ncb1202-e295 · Cited by 63 · see citing works
An Essential Role of Human Ada3 in p53 Acetylation
Nag, A., Germaniuk-Kurowska, A., Dimri, M., Sassack, M. A., Gurumurthy, C. B., Gao, Q., Dimri, G. P., Band, H., & Band, V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610443200 · Cited by 63 · see citing works
Kuballa, P., Matentzoglu, K., & Scheffner, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605117200 · Cited by 60 · see citing works
USP11 Stabilizes HPV-16E7 and Further Modulates the E7 Biological Activity
Lin, C.-H., Chang, H., & Yu, W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708278200 · Cited by 60 · see citing works
Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent
Grm, H. Š., & Banks, L. (2004) · Journal of General Virology · doi:10.1099/vir.0.80035-0 · Cited by 56 · see citing works
Bellanger, S., Demeret, C., Goyat, S., & Thierry, F. (2001) · Journal of Virology · doi:10.1128/jvi.75.16.7244-7251.2001 · Cited by 55 · see citing works
Toll-Like Receptors in Human Papillomavirus Infection
Zhou, Q., Zhu, K., & Cheng, H. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0220-7 · Cited by 55 · see citing works
Human Papilloma Virus (HPV) and Host Cellular Interactions
Mammas, I., Sourvinos, G., Giannoudis, A., & Spandidos, D. A. (2008) · Pathology & Oncology Research · doi:10.1007/s12253-008-9056-6 · Cited by 51 · see citing works
Chen, X., Sturgis, E. M., Lei, D., Dahlstrom, K. R., Wei, Q., & Li, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4733 · Cited by 48 · see citing works
Identification of annexin A1 as a novel substrate for E6AP‐mediated ubiquitylation
Shimoji, T., Murakami, K., Sugiyama, Y., Matsuda, M., Inubushi, S., Nasu, J., Shirakura, M., Suzuki, T., Wakita, T., Kishino, T., et al. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22096 · Cited by 48 · see citing works
p53 and MDM2 Expression in Oral Squamous Cell Carcinoma
Matsumura, T., Yoshihama, Y., Kimura, T., Shintani, S., & Alcalde, R. E. (2009) · Oncology · doi:10.1159/000227578 · Cited by 46 · see citing works
Differential Production of Cytokines and Activation of NF-κB in HPV-Transformed Keratinocytes
Havard, L., Delvenne, P., Frare, P., Boniver, J., & Giannini, S. L. (2002) · Virology · doi:10.1006/viro.2002.1468 · Cited by 43 · see citing works
Kehmeier, E. S., Rühl, H., Voland, B., Stoppler, M. C., Androphy, E. J., & Stöppler, H. (2002) · Virology · doi:10.1006/viro.2002.1502 · Cited by 41 · see citing works
Lin, H., Wang, Y., & Chiang, C. (2010) · Head & Neck · doi:10.1002/hed.21452 · Cited by 41 · see citing works
Bellanger, S., Tan, C. L., Nei, W. L., He, P., & Thierry, F. (2009) · Journal of Virology · doi:10.1128/jvi.01162-09 · Cited by 39 · see citing works
Tomakidi, P., Cheng, H., Kohl, A., Komposch, G., & Alonso, A. (2000) · Cell and Tissue Research · doi:10.1007/s004410000231 · Cited by 33 · see citing works
Decreased Expression of Annexin A1 during the Progression of Cervical Neoplasia
Ld, W., Yang, Y., Liu, Y., Ht, S., Zhang, L., & Pl, L. (2008) · Journal of International Medical Research · doi:10.1177/147323000803600407 · Cited by 32 · see citing works
Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18
Stewart, D. (2004) · Journal of General Virology · doi:10.1099/vir.0.19679-0 · Cited by 31 · see citing works
Fournier, N., Raj, K., Saudan, P., Utzig, S., Sahli, R., Simanis, V., & Beard, P. (1999) · Oncogene · doi:10.1038/sj.onc.1202775 · Cited by 28 · see citing works
Expression and mutational analysis of TGF-β/Smads signaling in human cervical cancers
Ki, K., Tong, S., Huh, C.-Y., Lee, J., Lee, S. K., & Chi, S.-G. (2009) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2009.20.2.117 · Cited by 27 · see citing works
Friedrich, R. E., Hagel, C., & Bartel-Friedrich, S. (2010) · PubMed · Cited by 27 · see citing works
E6AP gene suppression and characterization with in vitro selected hammerhead ribozymes
Kim, Y., Cairns, M. J., Marouga, R., & Sun, L. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700623 · Cited by 24 · see citing works
Insulin-Like Growth Factor Axis and Oncogenic Human Papillomavirus Natural History
Harris, T. G., Burk, R. D., Yu, H., MINKOFF, H. L., Massad, L. S., Watts, D. H., Ye, Z., Gange, S. J., Kaplan, R. C., Anastos, K., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0686 · Cited by 23 · see citing works
Santer, F. R., Moser, B., Spoden, G. A., Jansen‐Dürr, P., & Zwerschke, W. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm199 · Cited by 23 · see citing works
The Mdm2 Ubiquitin Ligase Enhances Transcriptional Activity of Human Papillomavirus E2
Gammoh, N., Gardiol, D., Massimi, P., & Banks, L. (2008) · Journal of Virology · doi:10.1128/jvi.01551-08 · Cited by 22 · see citing works
Ubiquitination in host immune response to human papillomavirus infection
Zhou, Q., Zhu, K., & Cheng, H. (2011) · Archives of Dermatological Research · doi:10.1007/s00403-011-1141-0 · Cited by 12 · see citing works
Hu, Y., Feng, Y., Lü, W., Hong, D., Wan, X., & Xie, X. (2009) · Cancer Investigation · doi:10.1080/07357900802350798 · Cited by 12 · see citing works
Zn2+ Fingers and Cervical Cancer
Foster, S. A., & Phelps, W. C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.14.1180 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
PROTAC targeted protein degraders: the past is prologue
Békés, M., Langley, D. R., & Crews, C. M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00371-6 · Cited by 3,395 · see citing works
The many substrates and functions of NEDD4-1
Huang, X., Chen, J., Cao, W., Yang, L., Chen, Q., He, J., Yi, Q., Huang, H., Zhang, E., & Cai, Z. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2142-8 · Cited by 114 · see citing works
The Ubiquitin-Conjugating System: Multiple Roles in Viral Replication and Infection
Calistri, A., Munegato, D., Carli, I., Parolin, C., & Palù, G. (2014) · Cells · doi:10.3390/cells3020386 · Cited by 91 · see citing works
Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge
Pešut, E., Đukić, A., Lulić, L., Skelin, J., Šimić, I., Gašperov, N. M., Tomaić, V., Sabol, I., & Grce, M. (2021) · Viruses · doi:10.3390/v13112234 · Cited by 93 · see citing works
The CXCL12/CXCR4 Signaling Pathway: A New Susceptibility Factor in Human Papillomavirus Pathogenesis
Meuris, F., Carthagéna, L., Jaracz‐Ros, A., Gaudin, F., Cutolo, P., Deback, C., Xue, Y., Thierry, F., Doorbar, J., & Bachelerie, F. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1006039 · Cited by 50 · see citing works
High-Risk Human Papillomavirus Targets Crossroads in Immune Signaling
Tummers, B., & van der Burg, S. (2015) · Viruses · doi:10.3390/v7052485 · Cited by 46 · see citing works
HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy?
Đukić, A., Lulić, L., Thomas, M., Skelin, J., Saidu, N. E. B., Grce, M., Banks, L., & Tomaić, V. (2020) · Pathogens · doi:10.3390/pathogens9020133 · Cited by 46 · see citing works
Structural Insights in Multifunctional Papillomavirus Oncoproteins
Suárez, I. P., & Travé, G. (2018) · Viruses · doi:10.3390/v10010037 · Cited by 39 · see citing works
Novel Insights Into E3 Ubiquitin Ligase in Cancer Chemoresistance
Yang, L., Chen, J., Huang, X., Zhang, E., He, J., & Cai, Z. (2017) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2017.12.012 · Cited by 24 · see citing works
Regulation of HPV E7 Stability by E6-Associated Protein (E6AP)
Vats, A., Trejo-Cerro, Ó., Massimi, P., & Banks, L. (2022) · Journal of Virology · doi:10.1128/jvi.00663-22 · Cited by 22 · see citing works
Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway
Yang, L., Chen, J., Han, X., Zhang, E., Huang, X., Guo, X., Chen, Q., Wu, W., Zheng, G., He, D., et al. (2018) · Protein & Cell · doi:10.1007/s13238-017-0500-9 · Cited by 17 · see citing works
The E3 Ligases in Cervical Cancer and Endometrial Cancer
Zhai, F., Wang, J., Yang, W., Ye, M., & Jin, X. (2022) · Cancers · doi:10.3390/cancers14215354 · Cited by 16 · see citing works
The Role of Ubiquitin and Ubiquitin-Like Modification Systems in Papillomavirus Biology
Wilson, V. G. (2014) · Viruses · doi:10.3390/v6093584 · Cited by 11 · see citing works
HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block
Rashid, N. N., Yong, Z. L., Yusof, R., & Watson, R. J. (2016) · Virology Journal · doi:10.1186/s12985-015-0460-8 · Cited by 10 · see citing works
Virophages and Their Interactions with Giant Viruses and Host Cells
Sobhy, H. (2018) · Proteomes · doi:10.3390/proteomes6020023 · Cited by 10 · see citing works
Celewicz, A., Celewicz, M., Michalczyk, M., & Rzepka, R. (2020) · Mediators of Inflammation · doi:10.1155/2020/2607594 · Cited by 9 · see citing works
Kurmyshkina, O. V., Kovchur, P. I., & Volkova, T. O. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.11.4477 · Cited by 6 · see citing works
Targeting the Ubiquitin Proteasome System in Cancer
Kumari, N., Lee, K. K., & Jha, S. (2018) · InTech eBooks · doi:10.5772/intechopen.76705 · Cited by 4 · see citing works
Regulation of human papillomavirus E6 oncoprotein function via a novel ubiquitin ligase FBXO4
Vats, A., Braga, L., Kavčič, N., Massimi, P., Schneider, E., Giacca, M., Laimins, L. A., & Banks, L. (2024) · mBio · doi:10.1128/mbio.02783-24 · Cited by 3 · see citing works
Singh, S., & Yadav, P. (2026) · Molecular Biotechnology · doi:10.1007/s12033-026-01561-6
- Authors
- Lou, Z., & Wang, S.
- Affiliations
- Sir Run Run Shaw Hospital (CN)
- Department of Stomatology, 118th Hospital of PLA, Wenzhou, People’s Republic of China
- Corresponding author
- Wang, Sheng
- ORCID
- Wang, Sheng
- Venue
- Journal of International Medical Research
- Publisher
- SAGE Publications
- Published
- 2014-01-20
- Volume
- 42
- Issue
- 2
- Pages
- 247-260
- ISSN
- 0300-0605 (ISSN-L)
- 1473-2300
- OpenAlex
- W2158265519
- Cited by
- 22
- References
- 98
- Citations by year
- 2026: 1 · 2024: 2 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 2
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of International Medical Research (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- E3 ubiquitin ligase, human papillomavirus, HPV-induced carcinogenesis, ubiquitination, signaling pathways, cervical cancer
- MeSH terms
- Cell Transformation, Neoplastic, Uterine Cervical Neoplasms, Female, Humans, Viral Proteins, Signal Transduction, Papillomaviridae, Papillomavirus Infections, Ubiquitin-Protein Ligases, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review